During this year's epidemic, a number of traditional Chinese medicine preparations were included in the diagnosis and treatment program, becoming famous in the first World War. Novel coronavirus pneumonia has been repeatedly requested by the central government to carry out the epidemic treatment. The new crown pneumonia diagnosis and treatment plan has also been increasing, enriching and improving the use of Chinese medicine. Many Chinese medicines have been approved for clinical use. In the novel coronavirus pneumonia, the deep involvement of Chinese medicine has played a positive role.




With more and more patients discharged from hospital who were cured by Integrated Traditional Chinese and Western medicine or simply using traditional Chinese medicine, the value of traditional Chinese medicine has been highlighted. From the media reports, both the utilization rate of traditional Chinese medicine and the therapeutic effect have achieved remarkable results.




Recently, the novel coronavirus pneumonia treated by Chinese Academy of Sciences (Zhong Nanshan) has been published in the International Journal of plant medicine (Phytomedicine). It is reported that novel coronavirus Zhong Nanshan has been screened for more than forty Chinese patent medicines and Chinese medicine prescriptions in order to find and verify the effective Chinese medicine for the new crown disease prevention and control. It has proved that Lianhua Qingwen capsule and other Chinese medicines have a good inhibitory effect on cytopathic effects caused by new crown virus infection, and inhibit the activity of new coronavirus, reduce the content of virus, and significantly inhibit inflammation. Factor overexpression.




The central government attaches more importance to TCM




Traditional Chinese medicine (TCM) is a treasure of Chinese traditional culture and a medical and pharmaceutical system with a long history. At present, China is vigorously developing the cause of traditional Chinese medicine.




According to Xinhua news agency, the Central Committee held a symposium of experts and scholars in June 2nd. When general secretary Xi Jinping delivered an important speech, he stressed that people's safety is the cornerstone of national security. We must strengthen the bottom line thinking and enhance the sense of hardship. We should always guard against major risks in the field of health and health. Only by building a strong public health system, improving the early warning and response mechanism, comprehensively improving the ability of prevention, control and treatment, weaving dense protective nets and building solid separation walls, can we effectively provide a strong guarantee for the maintenance of people's health.




The meeting also pointed out that combining traditional Chinese medicine with western medicine is a major feature of the epidemic prevention and control. It is also a vivid practice of the essence of TCM inheritance and innovation. We should strengthen the carding and excavation of the essence of classical medical books, build a number of research support platforms, reform and improve the mechanism of examination and approval of Chinese medicine, and promote the development and development of new drugs. It is necessary to strengthen the construction of TCM service system and improve the emergency and treatment capacity of TCM hospitals. It is necessary to strengthen the construction of talents with Chinese medicine characteristics and build a high-level national team for prevention and treatment of epidemic diseases of traditional Chinese medicine. We should strengthen the organization and leadership of the work of traditional Chinese medicine and promote the complementary and coordinated development of Chinese and Western medicine.




At the same time, according to people's daily.com, Beijing has recently released a massive document to promote the development of traditional Chinese medicine. According to the Beijing Municipal Health Protection Committee, the relevant departments of Beijing drafted the "Beijing Municipal Chinese Medicine Ordinance (Draft for public draft)" and explained and openly solicited opinions. In this document, Beijing indicated that we should vigorously develop the cause of Chinese medicine, inherit the essence, keep the innovation, follow the law of the development of Chinese medicine, establish a management system that accords with the characteristics of Chinese medicine, and maintain and carry forward the traditional Chinese medicine. The characteristics and advantages of medicine promote the construction of healthy Beijing and the health of the people. In addition, the relevant departments should promote the transformation of economic resources industry with great potential of traditional Chinese medicine, formulate the development plan and supporting policies of traditional Chinese medicine industry, make full use of the relevant industry funds of the city, give full play to the advantages of scientific and technological innovation resources such as Zhongguancun Science and Technology Park and Beijing Economic and Technological Development Zone, and promote the high-quality development of Chinese medicine industry.




Re evaluation of traditional Chinese medicine injection may start




Traditional Chinese medicine injections have attracted much attention due to their safety problems. In recent years, the market share of traditional Chinese medicine injections has decreased significantly with the stricter supervision of the industry. At the same time, the related pharmaceutical enterprises have also been affected by the limited quality. However, after the reshuffle of the market and strict control, the adverse reaction rate of traditional Chinese medicine injection has been greatly reduced after the impact of "prescription restriction" of Chinese patent medicine, revision of instructions, medical insurance payment limit and key monitoring. In addition, in May 2020, the State Food and Drug Administration launched the conformity evaluation of generic drug injections. The industry generally believes that the introduction of this policy also gives hope to the re evaluation of traditional Chinese medicine injections.




Recently, the medical insurance bureau of Qinghai Province issued the notice on submitting the relevant data of purchasing drugs in 2020 by provincial organizations, which published the list of drugs purchased with volume in Qinghai Province in 2020, including 49 varieties of human serum albumin, Xuesaitong, Shenkang and butylphthalide. At this point, another provincial procurement catalog with volume has surfaced, causing industry concern. It is worth noting that the special procurement of antibiotics in Shanxi Province and 27 injections in Shandong Province were included in the provincial procurement. In addition, Qinghai Province has started the centralized procurement of Chinese patent medicines and traditional Chinese medicine injections. In the future, the varieties of national centralized drug procurement will be more diversified. With the introduction of traditional Chinese medicine injections into the collection of drugs, the consistency evaluation will also be put on the agenda.




In fact, as early as 2018, the State Food and Drug Administration planned to launch the post marketing re evaluation of traditional Chinese medicine injections. Up to now, the relevant regulatory policies have not been promulgated. Some analysts pointed out that the reason why the re evaluation of Chinese patent medicines and traditional Chinese medicine injections has been delayed for nearly two years, because there is no precedent in the world to learn from, and the national regulatory authorities need sufficient time to investigate, balance the interests of all parties, and formulate